Literature DB >> 25791242

Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor.

Joaquín Martinez-Lopez1, Ana Jimenez, Jorge Sanchez-Calero, Dolores Monteagudo, María Urbanowicz, Irene Cañamares-Orbis, Susana Cortijo-Cascajares, Rosa Ayala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25791242     DOI： 10.1007/s00277-015-2352-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis.

Authors:  Serena Pelusi; Federica Iuculano; Rosa Lombardi; Paolo Francione; Umberto Gianelli; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Intern Emerg Med       Date:  2018-09-14       Impact factor: 3.397

2.  Co-existence of myeloproliferative neoplasias and β-thalassemia with IVS-2-654 mutation-a case report.

Authors:  Cai Wu; Xuewu Zhang; Xingnong Ye; Dan Chen; Jie Jin; Jian Huang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.